RBF Capital’s Intermolecular, Inc. IMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-20,000
| Closed | -$23K | – | 413 |
|
|
2019
Q2 | $23K | Sell |
20,000
-37,471
| -65% | -$43K | ﹤0.01% | 389 |
|
|
2019
Q1 | $66K | Hold |
57,471
| – | – | 0.01% | 368 |
|
|
2018
Q4 | $58K | Hold |
57,471
| – | – | 0.01% | 380 |
|
|
2018
Q3 | $67K | Buy |
57,471
+14,400
| +33% | +$20.6K | 0.01% | 393 |
|
|
2018
Q2 | $75K | Hold |
43,071
| – | – | 0.01% | 374 |
|
|
2018
Q1 | $55K | Hold |
43,071
| – | – | 0.01% | 369 |
|
|
2017
Q4 | $59K | Hold |
43,071
| – | – | 0.01% | 364 |
|
|
2017
Q3 | $45K | Hold |
43,071
| – | – | 0.01% | 357 |
|
|
2017
Q2 | $39K | Hold |
43,071
| – | – | 0.01% | 352 |
|
|
2017
Q1 | $40K | Hold |
43,071
| – | – | 0.01% | 358 |
|
|
2016
Q4 | $49K | Hold |
43,071
| – | – | 0.01% | 361 |
|
|
2016
Q3 | $43K | Buy |
43,071
+24,100
| +127% | +$29.7K | 0.01% | 361 |
|
|
2016
Q2 | $28K | Buy |
+18,971
| New | +$38.3K | 0.01% | 363 |
|
RBF Capital's IMI Position: Q3 2019 in Review
RBF Capital sold out of Intermolecular, Inc. (IMI) in Q3 2019, closing a stake of 20,000 shares — an estimated $23K sold.
RBF Capital first reported a position in IMI in Q2 2016 and held it in 13 quarters. The position peaked at $75K in Q2 2018. 0 funds tracked by Wall St. Rank hold IMI as of Q3 2019.
- RBF Capital reported no remaining Intermolecular, Inc. position as of Q3 2019 after selling out during the quarter.
- RBF Capital sold 20,000 Intermolecular, Inc. shares in Q3 2019, an estimated $23K.
- RBF Capital first reported a position in Intermolecular, Inc. in Q2 2016 and held it in 13 quarters.
- RBF Capital's Intermolecular, Inc. position peaked at $75K in Q2 2018.
- 0 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q3 2019.
Based on RBF Capital's 13F filing for Q3 2019, filed 13 Nov 2019.